Author

Courtnee V. Rodgers

Observed name: Courtnee Rodgers

Institutions: Northwestern University, Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Observed institutions: Northwestern University, University of Chicago, Robert H. Lurie Comprehensive Cancer Center of Northwestern University

OpenAlex ID: A5113061704

Predisposition to hematopoietic malignancies by deleterious germline CHEK2 variants

2025 · Ryan J. Stubbins, Stephen Arnovitz, et al. · Leukemia · 16

Overall cancer risk in people with deleterious germline DDX41 variants

2025 · Sophia C. Korotev, Jason X. Cheng, et al. · Haematologica · 6

Sequential tumor molecular profiling identifies likely germline variants

2023 · Ira L. Kraft, Hatice Basdag, et al. · Genetics in Medicine · 6

Germline cancer risk alleles drive myelodysplastic neoplasms throughout adulthood

2026 · Taylor D. Walker, Ashwin L. Koppayi, et al. · Leukemia

Outcomes of Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome in Recipients or Donors with Deleterious Likely Germline Variants

2026 · Ryan J. Stubbins, Amy M. Trottier, et al. · Transplantation and Cellular Therapy

FLT3 as a germ line driver in AML: expanding the landscape of leukemia predisposition

2026 · Alok Swaroop, Natasha L. Johnson, et al. · Blood Neoplasia

Frequency of Deleterious Pathogenic/Likely Pathogenic Germline Variants in Related and Unrelated Allogeneic Hematopoietic Cell Transplant Donors for Patients with Myelodysplastic Syndrome

2025 · Ryan J. Stubbins, Zachary S. Hattig, et al. · Transplantation and Cellular Therapy

Works count: 7

Citation count: 28

H-index: 3

I10-index: 1